| A cyclic peptide reproducing the α1 helix of VEGF-B binds to VEGFR-1 and VEGFR-2 and inhibits angiogenesis and tumor growth E Assareh, F Mehrnejad, K Mansouri, AR Esmaeili Rastaghi, ... Biochemical Journal 476 (4), 645-663, 2019 | 30 | 2019 |
| A VEGFB-based peptidomimetic inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK signaling and elicits apoptotic, antiangiogenic, and antitumor activities M Namjoo, H Ghafouri, E Assareh, AR Aref, E Mostafavi, ... Pharmaceuticals 16 (6), 906, 2023 | 5 | 2023 |
| Anti-tumor and anti-metastatic activity of the FGF2 118–126 fragment dependent on the loop structure H Allahmoradi, SM Asghari, A Ahmadi, E Assareh, M Nazari Biochemical Journal 479 (12), 1285-1302, 2022 | 3 | 2022 |
| Structural studies on an anti-angiogenic peptide using molecular modeling E Assareh, F Mehrnejad, SM Asghari Iranian Journal of Biotechnology 18 (4), e2553, 2020 | 2 | 2020 |
| A Review on COVID-19: Primary Receptor, Endothelial Dysfunction, Related Comorbidities, and Therapeutics (vol 47, pg 1, 2023) E Assareh, MA Abbasi, M Heidari, SM Asghari IRANIAN JOURNAL OF SCIENCE 47 (1), 325-325, 2023 | | 2023 |
| A Review on COVID-19: Primary Receptor, Endothelial Dysfunction, Related Comorbidities, and Therapeutics E Assareh, MA Abbasi, M Heidari, SM Asghari Iranian Journal of Science 47 (1), 1-25, 2023 | | 2023 |
| Combination Therapy in Cancer: Doxorubicin in Combination with an N-terminal Peptide of Endostatin Suppresses Angiogenesis and Stimulates Apoptosis in the Breast Cancer N Sarabi, R Chamani, E Assareh, O Saberi, SM Asghari International Journal of Molecular and Cellular Medicine 12 (2), 120, 2023 | | 2023 |
| Engineering of the C-terminal domain of Pseudomonas aeruginosa elastase: engineering of the second and third calcium-binding sites SM Asghari, SE Samani, E Assareh, H Rahmani 1st Tabriz International Life Science Conference and 12th Iran Biophysical …, 2013 | | 2013 |
